Zoledronsäure: Ist q12w so wirksam wie q4w?

Himelstein AL et al. JAMA. 2017;317(1):48–58.
Article CAS PubMed PubMed Central Google Scholar
Saad F et al. J Natl Cancer Inst. 2002;94(19):1458–68.
Article CAS PubMed Google Scholar
Saad F et al. J Natl Cancer Inst. 2004;96(11):879–82.
Article CAS PubMed Google Scholar
Rades D et al. Int J Radiat Oncol Biol Phys. 2011;79(2):524–30.
Article PubMed Google Scholar
Rades D et al. Strahlenther Onkol. 2012;188(10):910–6.
Article CAS PubMed Google Scholar
Smith MR et al. J Clin Oncol. 2014;32(11):1143–50.
Article CAS PubMed PubMed Central Google Scholar
Stopeck AT et al. J Clin Oncol. 2010;28(35):5132–9.
Article CAS PubMed Google Scholar
Fizazi K et al. Lancet. 2011;377(9768):813–22.
Article CAS PubMed PubMed Central Google Scholar
Henry DH et al. J Clin Oncol. 2011;29(9):1125–32.
Article CAS PubMed Google Scholar
Van Poznak CH et al. J Clin Oncol. 2011;29(9):1221–7.
Article PubMed Google Scholar
https://clinicaltrials.gov; NCT02051218

Himelstein AL et al. Effect of Longer-Interval vs Standard Dosing of Zoledronic Acid on Skeletal Events in Patients With Bone Metastases: A Randomized Clinical Trial. JAMA. 2017;317(1):48–58.
Article CAS PubMed PubMed Central Google Scholar

Author information

Klinik für Strahlentherapie der Universität zu Lübeck, Lübeck, Deutschland
Dirk Rades

Authors

Dirk Rades
View author publications
You can also search for this author in PubMed Google Scholar

Correspondence to Dirk Rades.

Erstpubliziert in Strahlenther Onkol. 2017;193(10):861-3.

Rades, D. Zoledronsäure: Ist q12w so wirksam wie q4w?. Info Onkol. 20, 24–26 (2017). https://doi.org/10.1007/s15004-017-5847-9

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.